Fundz

Bio Cardia, Inc. reported raising $35.9 Million in an initial SEC Form D filing, from an offering of $35.9 Million

PUBLIC · BCDANov 04, 2016

Amount Raised

$35.9 Million

$35.9 Million sold, per SEC Form D (first sale Nov 4, 2016)

Round Type

Venture

SunnyvaleBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

BioCardia raised $35.9 Million in a funding round, dated November 4, 2016. BioCardia is based in Sunnyvale, California, United States.

How much did BioCardia raise?
BioCardia raised $35.9 Million in a funding round on November 4, 2016.
What does BioCardia do?
BioCardia, Inc., headquartered in Sunnyvale, California, is a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease.
Where is BioCardia based and how big is it?
BioCardia is based in Sunnyvale, California, United States. Fundz records about 28 employees.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as BioCardia that raised within 45 days of this round, from Fundz verified event records.

  • ShockWave Medical raised $45M on November 22, 2016.
  • Crispr Therapeutics raised $35M on November 4, 2016.
  • TuHURA Biosciences raised an undisclosed amount on November 4, 2016.
  • Ocugen raised $30M on October 12, 2016.
  • Galectin raised $1.5M (Seed) on September 28, 2016.
  • INTRINSIC THERAPEUTICS raised $18M on December 16, 2016.

Who to call at BioCardia, and when

A new round usually means BioCardia is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BioCardia raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioCardia, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioCardia. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioCardia

Location

320 Soquel Way

Sunnyvale, California, United States

About

BioCardia, Inc., headquartered in Sunnyvale, California, is a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease. CardiAMP® autologous and CardiALLO™ allogeneic cell therapies are the Company’s biotherapeutic platforms with three clinical stage product candidates in development. These therapies are enabled by its Helix™ biotherapeutic delivery and Morph® vascular navigation product platforms.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioCardia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for BioCardia's next move

See what Strategic adds

BioCardia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.